Immunohematology Reagents NMCSD
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY HCD WEST
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT941026FE080
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents1
The Defense Health Agency (DHA), operating under the Department of Defense, has issued an award notice for the procurement of immunohematology reagents and related supplies for the Naval Medical Center San Diego (NMCSD). This procurement is intended to support the in-house blood bank operations by providing essential reagents and supplies necessary for the compatibility testing of blood products, the identification of antibodies in blood specimens, and the determination of transfusion needs for patients. By securing these reagents, the department aims to enhance its diagnostic capabilities, reduce reliance on external reference laboratories, and avoid additional costs associated with outsourcing specimen testing.
The scope of this procurement encompasses the supply of in-vitro diagnostic substances specifically designed for immunohematology applications. These products are critical for ensuring the safe and effective transfusion of blood products, as they enable the detection of potential incompatibilities and the identification of clinically significant antibodies. The intended outcome is to maintain a robust, self-sufficient blood bank operation that can promptly and accurately meet patient care requirements within the facility.
This procurement falls under the North American Industry Classification System (NAICS) code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and is further classified under Product Service Code (PSC) 6550, covering in vitro diagnostic substances, reagents, test kits, and sets. The place of performance for this contract is Bedford, Massachusetts, United States.
The contracting activity is managed by the Defense Health Agency HCD West office, a federal entity responsible for healthcare delivery and support within the Department of Defense. The primary point of contact for this procurement is Jason Willey ([email protected], 667-892-4029), with Tracy Robinson ([email protected], 726-203-0072) serving as the secondary contact.
This opportunity is not subject to any set-aside restrictions, indicating that it is open to all qualified vendors without limitations based on business size or socioeconomic status. Contractors interested in this type of work should have demonstrated capabilities in the manufacturing and supply of in-vitro diagnostic substances, particularly those used in immunohematology and blood bank settings.
For further details, including any available attachments, interested parties are encouraged to review the official notice on SAM.gov using Opportunity ID 93d3b9f08bec46d4937ae97db8d51edc or visit the provided URL: https://sam.gov/opp/93d3b9f08bec46d4937ae97db8d51edc/view.
This procurement represents a critical component of the DHA’s ongoing commitment to ensuring high-quality, cost-effective patient care through the reliable and timely provision of essential diagnostic reagents and supplies.